magent
Lyon 2020 HFA-ICOS baseline cardiovascular risk before second- or third-generation multi-targeted kinase inhibitors for CML targeting BCR-ABL. Class is very_high, high, medium, or low from published very-high and high factors plus Medium 1/
Go to this service →Our latest check (2026-10-11)
- Answering
- Yes — valid x402 payment terms
- Time to answer
- 208 ms
- Price
- $0.005 per call
- Paying buyers, last 30 days
- 1 (directory's own records)
- Paid calls, last 30 days
- 2
- Category
- Calculators and conversions
- Address
- https://api.magentlab.com/api/calc/hfa_icos_bcr_abl
Accuracy: paid answers checked against an independent record
Not yet in our paid checks. A seller we have not checked has neither passed nor failed.
For agents
This page as JSON: /sellers/d9fd4de3416c.json. Paid lookup by address: GET /api/seller?resource=… ($0.001, x402).